CHINA NARRATIVE MEDICINE MEDIA CO., LIMITED is a business entity registered in the Hong Kong Special Administrative Region of the People's Republic of China. Incorporated on 12-07-2016, it is a Private company limited by shares and its former company registration number was 2401997.
Since 27-12-2023, The Government of the Hong Kong SAR has been using Business Registration Number (BRN) as unique identifier for business entities in Hong Kong. The 8-digit business registration number for CHINA NARRATIVE MEDICINE MEDIA CO., LIMITED is 66413079.
The registration address of CHINA NARRATIVE MEDICINE MEDIA CO., LIMITED is UNIT 1405A 14/F, THE BELGIAN BANK BUILDING, NOS. 721-725 NATHAN ROAD, MONGKOK, KLN, HONG KONG. According to open business data, the registration status of this company is DEREGISTERED
中國敘事醫學傳媒有限公司是一家於中華人民共和國香港特別行政區註冊的私人股份有限公司。 它成立於 12-07-2016,公司註冊號碼是 2401997。
自2023年12月27日起,香港特別行政區政府使用商業登記號碼(BRN)作為香港商業實體的唯一識別碼。中國敘事醫學傳媒有限公司 的 8 位商業登記號碼是 66413079。
中國敘事醫學傳媒有限公司的公司註冊地址為 UNIT 1405A 14/F, THE BELGIAN BANK BUILDING, NOS. 721-725 NATHAN ROAD, MONGKOK, KLN, HONG KONG 。根據公開資料,它的註冊狀況是 已撤銷
Our AI model infers that CHINA NARRATIVE MEDICINE MEDIA CO., LIMITED has a high probability of participation in the business sector of pharmacies and medicine companies.
根據我們的人工智能模型推演,中國敘事醫學傳媒有限公司有較高的機率從事 藥房和醫藥公司 業務。
The above profile is compiled with data available from public domains. This is not an official webpage of the aforesaid company.
The delegation of the Hong Kong Special Administrative Region Government and business sector representatives led by Chief...
The Government today released the Blueprint for Arts & Culture & Creative Industries Development, which se...
The Hong Kong Special Administrative Region Government today said it strongly disapproves of and firmly rejects a letter ...
Chief Secretary Chan Kwok-ki today led a delegation of the Hong Kong Special Administrative Region Government and busines...
A delegation of the Hong Kong Special Administrative Region Government and senior representatives of the business sector,...
The Innovation & Technology Commission is inviting applications for the 2024/25 Innovation & Technology Suppor...